Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Portland location
Access al amyloidosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related al amyloidosis treatment provided free
Check if you qualify for this al amyloidosis clinical trial in Portland, OR
No-Cost Study Care
Local to Portland
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the overproduction of AL that are secreted by clonal bone marrow plasma cells. This is a study to determine adverse events and change in disease activity in adult participants with AL amyloidosis treated with ABBV-383. Etentamig (ABBV-383) is an investigational drug being developed for the treatment of AL amyloidosis. This study in broken into
Sponsor: AbbVie
Yes, this clinical trial (NCT06158854) has an active research site in Portland, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for al amyloidosis treatment options in Portland, OR, this clinical trial (NCT06158854) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all al amyloidosis clinical trials near you to find additional studies recruiting in your area.
See all amyloidosis clinical trials recruiting in Portland — not just this study.
Browse Amyloidosis Trials in Portland →